When it comes to treating canine osteoarthritis (OA), you already know that an NSAID is an important element of your multimodal treatment approach for your patients, even for your patients who have mild to moderate signs of OA.
Did you know that Galliprant can be used for all stages of OA, from earliest clinical signs?** You can help get your patients moving again so that they can share moments that matter with their owners. Watch our video below.
**Approved for use in dogs older than 9 months of age and greater than 8 pounds
Consider Galliprant as part of your patients’ canine OA treatment plan. It’s a first-in-class non-COX inhibiting NSAID1 that’s safe to use daily.
Indication
Galliprant is an NSAID that controls pain and inflammation associated with osteoarthritis in dogs.
Important Safety Information
Not for use in humans. For use in dogs only. Keep this and all medications out of reach of children and pets. Store out of reach of dogs and other pets in a secured location in order to prevent accidental ingestion or overdose. Do not use in dogs that have a hypersensitivity to grapiprant. If Galliprant is used long term, appropriate monitoring is recommended. Concomitant use of Galliprant with other anti-inflammatory drugs, such as COX-inhibiting NSAIDs or corticosteroids, should be avoided. Concurrent use with other anti-inflammatory drugs or protein-bound drugs has not been studied. The safe use of Galliprant has not been evaluated in dogs younger than 9 months of age and less than 8 lbs (3.6 kg), dogs used for breeding, pregnant or lactating dogs, or dogs with cardiac disease. The most common adverse reactions were vomiting, diarrhea, decreased appetite, and lethargy. Click here for full prescribing information.
PM-US-20-1626
©2020 Elanco or its affiliates. Elanco, Galliprant and the diagonal bar logo are trademarks of Elanco or its affiliates.
|